Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bimmer E Claessen

Showing results (11-20 of 134) with videos related to

Pageof 14
Sort By:
Journal of the American College of Cardiology|October 27, 2018
Paravalvular Leak: An Interesting Interplay of Acquired vWF-Disease and Late Bleeding After TAVRRoxana Mehran, Sabato Sorrentino, Bimmer E Claessen
Circulation. Cardiovascular Interventions|September 17, 2019
Minding the Microcirculation: Is it Worth the Effort?Bimmer E Claessen, Davide Cao, Roxana Mehran
International Journal of Cardiology|May 1, 2018
Patient delay in women with STEMI: Time to raise awarenessBimmer E Claessen, José P S Henriques
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 13, 2018
Acute myocardial infarction, chronic total occlusion, and cardiogenic shock: the ultimate triple threatBimmer E Claessen, Jose P S Henriques
JACC. Cardiovascular Interventions|August 3, 2020
FFR in the Setting of ACS: Can We Do Better?Bimmer E Claessen, Diederik F van Wijk
Interventional Cardiology Clinics|June 6, 2017
Balance of Ischemia and Bleeding in Selecting an Antithrombotic RegimenBimmer E Claessen, George D Dangas, Roxana Mehran
Critical Care Medicine|December 19, 2013
Does the association between a high body mass index and hospital mortality weigh "heavily" on the association between a low body mass index and hospital mortality?Bimmer E Claessen, Kai E Klopper, Marcus J Schultz
Current Pharmaceutical Design|January 7, 2011
Clinical studies with sirolimus, zotarolimus, everolimus, and biolimus A9 drug-eluting stent systemsBimmer E Claessen, José P S Henriques, George D Dangas
European Heart Journal|December 28, 2020
Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journeyDavide Cao, Rishi Chandiramani, Mauro Chiarito, et al.
Open Heart|October 30, 2015
Physiology-guided myocardial revascularisation in complex multivessel coronary artery disease: beyond the 2014 ESC/EACTS guidelines on myocardial revascularisationJan J Piek, Bimmer E Claessen, Justin E Davies, et al.
Pageof 14

Showing results (11-20 of 134) with videos related to

Sort By:
Pageof 14
Journal of the American College of Cardiology|October 27, 2018
Paravalvular Leak: An Interesting Interplay of Acquired vWF-Disease and Late Bleeding After TAVRRoxana Mehran, Sabato Sorrentino, Bimmer E Claessen
Circulation. Cardiovascular Interventions|September 17, 2019
Minding the Microcirculation: Is it Worth the Effort?Bimmer E Claessen, Davide Cao, Roxana Mehran
International Journal of Cardiology|May 1, 2018
Patient delay in women with STEMI: Time to raise awarenessBimmer E Claessen, José P S Henriques
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 13, 2018
Acute myocardial infarction, chronic total occlusion, and cardiogenic shock: the ultimate triple threatBimmer E Claessen, Jose P S Henriques
JACC. Cardiovascular Interventions|August 3, 2020
FFR in the Setting of ACS: Can We Do Better?Bimmer E Claessen, Diederik F van Wijk
Interventional Cardiology Clinics|June 6, 2017
Balance of Ischemia and Bleeding in Selecting an Antithrombotic RegimenBimmer E Claessen, George D Dangas, Roxana Mehran
Critical Care Medicine|December 19, 2013
Does the association between a high body mass index and hospital mortality weigh "heavily" on the association between a low body mass index and hospital mortality?Bimmer E Claessen, Kai E Klopper, Marcus J Schultz
Current Pharmaceutical Design|January 7, 2011
Clinical studies with sirolimus, zotarolimus, everolimus, and biolimus A9 drug-eluting stent systemsBimmer E Claessen, José P S Henriques, George D Dangas
European Heart Journal|December 28, 2020
Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journeyDavide Cao, Rishi Chandiramani, Mauro Chiarito, et al.
Open Heart|October 30, 2015
Physiology-guided myocardial revascularisation in complex multivessel coronary artery disease: beyond the 2014 ESC/EACTS guidelines on myocardial revascularisationJan J Piek, Bimmer E Claessen, Justin E Davies, et al.
Pageof 14